Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR3A and FCGR2A polymorphisms. (Record no. 22018025)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02098 a2200625 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250516104924.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201301s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1528-0020 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1182/blood-2012-05-431825 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Ghesquières, Hervé |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20130110 |
| 245 00 - TITLE STATEMENT | |
| Title | Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR3A and FCGR2A polymorphisms. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Blood |
| Date of publication, distribution, etc. | Sep 2012 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 2650-7 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged, 80 and over |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal, Murine-Derived |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Agents |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Follow-Up Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | International Agencies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Lymphoma, Follicular |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Polymorphism, Single Nucleotide |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prognosis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prospective Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Receptors, IgG |
| General subdivision | genetics |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Remission Induction |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Rituximab |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Survival Rate |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cartron, Guillaume |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Seymour, John Francis |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Delfau-Larue, Marie-Hélène |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Offner, Fritz |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Soubeyran, Pierre |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Perrot, Aurore |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Brice, Pauline |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bouabdallah, Réda |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sonet, Anne |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dupuis, Jehan |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Casasnovas, Olivier |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Catalano, John Vincent |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Delmer, Alain |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jardin, Fabrice |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Verney, Aurélie |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dartigues, Peggy |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Salles, Gilles |
| 773 0# - HOST ITEM ENTRY | |
| Title | Blood |
| Related parts | vol. 120 |
| -- | no. 13 |
| -- | p. 2650-7 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1182/blood-2012-05-431825">https://doi.org/10.1182/blood-2012-05-431825</a> |
| Public note | Available from publisher's website |
No items available.